Background glaucoma Shape Background glaucoma Shape Background glaucoma Shape
Grants > Heat Shock Proteins in Experimental Glaucoma Updated On: Ene. 23, 2025
National Glaucoma Research Grant

Heat Shock Proteins in Experimental Glaucoma

Principal Investigator

Cynthia Grosskreutz, MD, PhD

Massachusetts Eye and Ear Infirmary

Boston, MA, USA

About the Research Project

Program

National Glaucoma Research

Award Type

Standard

Award Amount

$90,000

Active Dates

April 01, 2005 - March 31, 2007

Grant ID

G2005026

Summary

Heat shock proteins (HSP) are a group of highly conserved proteins that act in a coordinated response to environmental and physiological stress. It has been recently observed that one member of this protein family, HSP27, is elevated in certain genetic models of glaucoma. Dr. Grosskreutz hopes to discover whether experimentally increasing HSP27 levels in the eye will prevent neuronal death in the retina in glaucoma. She will apply this gene therapy to increase and decrease HSP27 levels in the retina and record changes. Together, these results will provide important new information regarding the role of heat shock proteins in retinal ganglion cell death in glaucoma, and provide clues to new neuroprotective treatment approaches for this blinding disease.